Modern Mobility Aids (MDRM) 0.0170 $MDRM
Galileo Life Sciences terminates option agreement with Easton Pharmaceuticals
M2 - Fri Jun 19, 4:01AM CDT
Galileo Life Sciences Inc (OTC PINK: MDRM) (formerly Modern Mobility Aids Inc) announced on Thursday that as a result of several breaches of agreement, it has terminated its option agreement with Easton Pharmaceuticals of Toronto.
Galileo Life Sciences Reports Significant Progress
Marketwired - Tue Jun 09, 6:00AM CDT
Galileo Life Sciences, Inc. ("the Company"
(OTC PINK: MDRM), formerly Modern Mobility Aids Inc., announced today that it is nearing its goal of becoming a licensed Canadian producer and distributor of high quality medical marijuana under Health Canada's Marihuana Medical Purposes Regulations ("MMPR".
Modern Mobility Aids, Inc. Announces Name Change
ACCESSWIRE - Fri Dec 12, 6:46AM CST
TORONTO, ON / ACCESSWIRE / December 12, 2014 / Modern Mobility Aids, Inc. ("the Company" (OTC Pink: MDRM) announced today that the Board of Directors and shareholders approved the Company's name change to Galileo Life Sciences, Inc.
Modern Mobility Aids, Inc. Provides Update on Investments in Medical Cannabis, Innovative Health Science Products and New Marketing Initiatives
ACCESSWIRE - Mon Dec 08, 8:39AM CST
TORONTO, ON / ACCESSWIRE / December 8, 2014 / Modern Mobility Aids, Inc. (OTC Pink: MDRM) (the "Company", announced today progress on a number of its health science and marketing and communications initiatives.
Modern Mobility Aids, Inc. Announces Formation of Medical Advisory Board
ACCESSWIRE - Tue Nov 04, 8:31AM CST
TORONTO, ON / ACCESSWIRE / November 4, 2014 / Nevada-based Modern Mobility Aids, Inc. (OTC Pink: MDRM) (the "Company", a medical device and Biopharma company, announces that it has created a Medical Advisory Board for the Company, and in an earlier press release announced that Dr. Baseer Khan, the Company's Chief Medical Director, will serve as Chairman.
Galileo Life Sciences terminates option agreement with Easton Pharmaceuticals
M2 - Fri Jun 19, 4:01AM CDT
Galileo Life Sciences Inc (OTC PINK: MDRM) (formerly Modern Mobility Aids Inc) announced on Thursday that as a result of several breaches of agreement, it has terminated its option agreement with Easton Pharmaceuticals of Toronto.
Galileo Life Sciences Reports Significant Progress
Marketwired - Tue Jun 09, 6:00AM CDT
Galileo Life Sciences, Inc. ("the Company"
(OTC PINK: MDRM), formerly Modern Mobility Aids Inc., announced today that it is nearing its goal of becoming a licensed Canadian producer and distributor of high quality medical marijuana under Health Canada's Marihuana Medical Purposes Regulations ("MMPR". Modern Mobility Aids, Inc. Announces Name Change
ACCESSWIRE - Fri Dec 12, 6:46AM CST
TORONTO, ON / ACCESSWIRE / December 12, 2014 / Modern Mobility Aids, Inc. ("the Company"
(OTC Pink: MDRM) announced today that the Board of Directors and shareholders approved the Company's name change to Galileo Life Sciences, Inc. Modern Mobility Aids, Inc. Provides Update on Investments in Medical Cannabis, Innovative Health Science Products and New Marketing Initiatives
ACCESSWIRE - Mon Dec 08, 8:39AM CST
TORONTO, ON / ACCESSWIRE / December 8, 2014 / Modern Mobility Aids, Inc. (OTC Pink: MDRM) (the "Company"
, announced today progress on a number of its health science and marketing and communications initiatives. Modern Mobility Aids, Inc. Announces Formation of Medical Advisory Board
ACCESSWIRE - Tue Nov 04, 8:31AM CST
TORONTO, ON / ACCESSWIRE / November 4, 2014 / Nevada-based Modern Mobility Aids, Inc. (OTC Pink: MDRM) (the "Company"
, a medical device and Biopharma company, announces that it has created a Medical Advisory Board for the Company, and in an earlier press release announced that Dr. Baseer Khan, the Company's Chief Medical Director, will serve as Chairman. 
